These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 6330266

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dynamics and mechanics of corticosteroid feedback at the hypothalamus and anterior pituitary gland.
    Jones MT, Hillhouse EW, Burden JL.
    J Endocrinol; 1977 Jun; 73(3):405-17. PubMed ID: 194993
    [Abstract] [Full Text] [Related]

  • 3. In-vitro effects of corticosterone, synthetic ovine corticotrophin releasing factor and arginine vasopressin on the release of adrenocorticotrophin by fetal rat pituitary glands.
    Dupouy JP, Chatelain A.
    J Endocrinol; 1984 Jun; 101(3):339-44. PubMed ID: 6327872
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Corticotrope response to removal of releasing factors and corticosteroids in vivo.
    Dallman MF, Makara GB, Roberts JL, Levin N, Blum M.
    Endocrinology; 1985 Nov; 117(5):2190-7. PubMed ID: 2995008
    [Abstract] [Full Text] [Related]

  • 6. Corticotrophin-releasing factor--mediated adrenocorticotrophin release from rat anterior pituitary cells is potentiated by C-terminal gastrin-releasing peptide.
    Hale AC, Price J, Ackland JF, Doniach I, Ratter S, Besser GM, Rees LH.
    J Endocrinol; 1984 Aug; 102(2):R1-R3. PubMed ID: 6086800
    [Abstract] [Full Text] [Related]

  • 7. Rapid as well as delayed inhibitory effects of glucocorticoid hormones on pituitary adrenocorticotropic hormone release are mediated by type II glucocorticoid receptors and require newly synthesized messenger ribonucleic acid as well as protein.
    Dayanithi G, Antoni FA.
    Endocrinology; 1989 Jul; 125(1):308-13. PubMed ID: 2544406
    [Abstract] [Full Text] [Related]

  • 8. ACTH release in pituitary cell cultures. Effect of neurogenic peptides and neurotransmitter substances on ACTH release induced by hypothalamic corticotropin releasing factor (CRF).
    Hashimoto K, Yunoki S, Takahara J, Ofuji T.
    Endocrinol Jpn; 1979 Feb; 26(1):103-9. PubMed ID: 35343
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro.
    Tsagarakis S, Navarra P, Rees LH, Besser M, Grossman A, Navara P.
    Endocrinology; 1989 May; 124(5):2330-5. PubMed ID: 2539975
    [Abstract] [Full Text] [Related]

  • 11. Diurnal variations in responsiveness of the hypothalamo-pituitary-adrenocortical axis of the rat.
    Nicholson S, Lin JH, Mahmoud S, Campbell E, Gillham B, Jones M.
    Neuroendocrinology; 1985 Mar; 40(3):217-24. PubMed ID: 2986024
    [Abstract] [Full Text] [Related]

  • 12. Hypothalamus, anterior pituitary and adrenal gland involvement in the activation of adrenocorticotropin and corticosterone secretion by gastrin-releasing peptide.
    Garrido MM, Manzanares J, Fuentes JA.
    Brain Res; 1999 May 15; 828(1-2):20-6. PubMed ID: 10320721
    [Abstract] [Full Text] [Related]

  • 13. ACTH content in the anterior pituitary after the infusion of various doses of corticosterone and dexamethasone in normal and adrenalectomized rats.
    Sakakura M, Yoshioka M, Kobayashi M.
    Tohoku J Exp Med; 1982 Jun 15; 137(2):191-8. PubMed ID: 6287667
    [Abstract] [Full Text] [Related]

  • 14. Effects of serotonin, cyproheptadine and reserpine on corticotropin-releasing factor release from the rat hypothalamus in vitro.
    Nakagami Y, Suda T, Yajima F, Ushiyama T, Tomori N, Sumitomo T, Demura H, Shizume K.
    Brain Res; 1986 Oct 29; 386(1-2):232-6. PubMed ID: 3022879
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prolactin-releasing peptide and its homolog RFRP-1 act in hypothalamus but not in anterior pituitary gland to stimulate stress hormone secretion.
    Samson WK, Keown C, Samson CK, Samson HW, Lane B, Baker JR, Taylor MM.
    Endocrine; 2003 Oct 29; 20(1-2):59-66. PubMed ID: 12668869
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.
    Hadley AJ, Kumari M, Cover PO, Osborne J, Poyser R, Flack JD, Buckingham JC.
    Br J Pharmacol; 1996 Oct 29; 119(3):463-70. PubMed ID: 8894165
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE, Kamilaris TC, Gomez MT, Johnson EO, Tartaglia ME, Gold PW, Chrousos GP.
    Endocrinology; 1989 Nov 29; 125(5):2445-53. PubMed ID: 2551652
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.